(Date:11/23/2009)...Y,Mo.,Nov.23/PRNewswire/--ChristineHoehnehasjoined...nedinsurancebrokerage.HoehnewillserveasanAccountEx...acticeinLockton,s Minneapolis office. ,, (Logo:...351LOGO ) ,, "WearethrilledtohaveChristinejoino...nalBenefitServices."Shebroadensourabilitytoassisto...
(Date:11/23/2009)...suggest that adding flaxseed oil to the diet could...l women and women with diabetes, according to a re... of Food Safety, Nutrition and Public Health . , ... Center, in Cairo, Egypt, have studied the effect ...eed oil in the diet might delay the onset of osteo...
(Date:11/23/2009)... Suite Helps Organizations Meet HIPAA Comp...Enrollment and Eligibility, , ...national, a leading provider of high-performance d...nounced today the launch of new products within it...roviders and other healthcare organizations meet i...
(Date:11/23/2009)...have it take longer to get sick, study finds , ...tists report that a genetic variation appears to p... HIV-infected patients. , In fact, those with...lop AIDS and die of complications of the disease. ...s individuals that make a person more or less susc...
(Date:11/23/2009)...OPEKIDSTOSHOOT15MILLIONFREETHROWSIN2010WORLD,SLARG...NS12-CITYU.S.TOUR&TRIPTOAFRICANEXTYEAR ,, ...ESTSHOT" ,, SEATTLE,Nov.23/PRNewswire-USNewswi...V/AIDS,thousandsnationwidewilltakepartin HoopsofHo...heheartofthemovementis15-year-old AustinGutwein fr...
Breaking Medicine News(10 mins):Health News:Lockton Benefit Group Expands International Benefit Team 2Health News:Flaxseed oil and osteoporosis 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 3Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 4Health News:Genetic Variant Slows AIDS Progression 2Health News:Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 2Health News:Arizona Youth Urges Thousands to Join Him for World AIDS Day Activities In December 3...st, creepiest surprise this Halloween may actually... this Saturday at the American Heart Association c...f as many mini-size Halloween candies when they ke...aturday at the American Heart Association conferen...
... 30, 2007 Thresholds limiting bariatric surgeries...t access for poor and underinsured patients, popul...n analysis led by UT Southwestern Medical Center r...ries under Medicare and Medicaid because some stud...
..., Oct. 30 Medarex, Inc.,(Nasdaq: MEDX ) announce...organ Small/Mid Cap Conference in Boston on Monday...ex,s presentation will be webcast live and will,be... About Medarex Medarex is a biopharmaceutical com...
...f., Oct. 30 Anthera Pharmaceuticals,Inc., a priva...i-inflammatory drugs for chronic and acute disease...appointed to Anthera,s Board of Directors. "Don,s...o large scale Phase III clinical trials," said Pau...
...ic Set to Be First in UK to Offer RapidArc(TM) and...ONDON, Oct. 30 The London Clinic is set to,be the...ed RapidArc(TM),treatments as part of a long-term ...irst in the UK to acquire an,advanced Trilogy(R) a...
...lands, October 30 Organon, the human,healthcare b...t has signed,an exclusive, worldwide license agree...t and commercialization of several antithrombotic ...cology. Under the terms of the agreement, Endotis...
Other Medicine News:Health News:Food 'tricks' that combat sneaky, creepy Halloween treats 2Health News:Government restrictions on weight loss surgeries limit access for poor, underinsured patients 2Health News:Government restrictions on weight loss surgeries limit access for poor, underinsured patients 3Health News:Anthera Pharmaceuticals, Inc. Appoints Donald Santel to Board of Directors 2Health News:Prestigious London Hospital Enters Long-Term Agreement with Varian Medical Systems 2Health News:Prestigious London Hospital Enters Long-Term Agreement with Varian Medical Systems 3Health News:Organon Signs an Exclusive, Worldwide Licence Agreement on Advanced Antithrombotic Compounds With Endotis Pharma 2Health News:Organon Signs an Exclusive, Worldwide Licence Agreement on Advanced Antithrombotic Compounds With Endotis Pharma 3Health News:Organon Signs an Exclusive, Worldwide Licence Agreement on Advanced Antithrombotic Compounds With Endotis Pharma 4(Date:11/23/2009)..., THEWOODLANDS,Texas,Nov.23/PRNewswire-FirstCall/...ouncedtodaythattop-linedatafromitsPhase2clinicalst...ablebowelsyndrome(IBS)willbepresentedatGASTRO2009i...gnificantimprovementinIBSsymptoms,willbepresentedb...clinicaldevelopment,onNovember25,2009at2:30pmlocal...
(Date:11/23/2009)..., LINCOLNSHIRE,Ill.,Nov.23/PRNewswire/--Sarnova,I...careproductsintheemergencymedicalservices(EMS)andr...fourexecutivestoitsseniormanagementteam.Thenewexec...s;DonnaHill,executivevicepresidentandgeneralcounse...GregRobitaille,executivevicepresidentofcorporatede...
(Date:11/23/2009)..., INDIANAPOLIS,Nov.23/PRNewswire/--AMDLASERSannou...todentaleducationbypartneringwithprestigiousindust...casso,byAMDLASERS,willbetheexclusivesofttissuediod...ies,whicharetargetedtothetop2%ofdentists. ,, (P.../DE98219 ) ,, "ItiswithgreatpleasurethatIproudl...
Breaking Medicine Technology:Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 2Lexicon to Present Positive Top-Line Phase 2 Results for LX1031 in Non-Constipating Irritable Bowel Syndrome at GASTRO 2009 3Sarnova Expands Senior Management Team 2AMD LASERS Announces New Partnership with Dr. Larry Rosenthal and Aesthetic Advantage 2Sticky protein helps reinforce fragile muscle membranes 9329 1Sticky protein helps reinforce fragile muscle membranes 9329 2Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 1Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi3 Clinical Trial of R788 in Rheumatoid Arthritis 52567 2Miller McCune Magazine Wins Environmental Journalism Prize 52565 1Miller McCune Magazine Wins Environmental Journalism Prize 52565 2...Mechanism and Demonstrate Significant Tumor ...n Mice, PALO ALTO, Calif., April 14 Intradigm Co...ic RNA interference (RNAi),therapeutics, today ann...,s,RNAi Nanoplex (NPX) delivery technology platfor...fering RNAs (siRNAs) targeting both vascular,endot...
...rogen,Pharmaceuticals Limited (ASX: PGL) (Nasdaq: ...data on its patented PG500 series of compounds at ...h (AACR) meeting being held,in San Diego. The meet...nts,from around the world to discuss new and signi...auses, diagnosis, treatment and prevention of,canc...
Other Medicine Technology:Study Shows Intradigm's RNAi Nanoplex Technology To Be Effective Systemic siRNA Delivery Platform for the Treatment of Various Cancer Models 2Study Shows Intradigm's RNAi Nanoplex Technology To Be Effective Systemic siRNA Delivery Platform for the Treatment of Various Cancer Models 3PG500 Series Presented at the AACR Annual Meeting in San Diego 2...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
...ries is a national reference laboratory and a worl... development. ARUP offers an extensive test menu o...cal and anatomic pathology. Owned by the Universit... than half of the nation's university teaching hos...
Medicine Products: